SCHEMBL7412470

SCHEMBL7412470

Cc1ccc(-c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.62
LMNA P02545 1/20 0.62
TSHR P16473 1/20 0.62
ALOX12 P18054 1/20 0.62
ALDH1A1 P00352 5/20 0.60
TDP1 Q9NUW8 4/20 0.58
RAB9A P51151 4/20 0.58
HPGD P15428 3/20 0.58
NPC1 O15118 3/20 0.58
NFKB1 P19838 2/20 0.58
NFKB2 Q00653 2/20 0.58
RELA Q04206 2/20 0.58
POLB P06746 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22079642 1.00 ACHE (0.62) ACHELMNATSHRALOX12ALDH1A1
SCHEMBL587 1.00 ACHE (0.62) ACHELMNATSHRALOX12ALDH1A1
Tannin Pyrogallol SCHEMBL1419994 1.00 ACHE (0.62) ACHELMNATSHRALOX12ALDH1A1
SCHEMBL29220723 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
SCHEMBL22802548 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
Ammonia Solution, Strong SCHEMBL23824902 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
SCHEMBL28926317 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
Lithium SCHEMBL30864208 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
Hydrochloric Acid SCHEMBL7987604 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1
Water SCHEMBL11019701 0.97 ACHE (0.59) ACHELMNATSHRALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371370-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE SAMSUNG SDI CO LTD (KR) 2023-11-16 US disclosed
US-11800794-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device SAMSUNG SDI CO., LTD. (KR) 2023-10-24 US disclosed
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 US disclosed
US-20230134165-A1 COMPOSITION AND LIGHT EMITTING DEVICE CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-05-04 US disclosed
US-20230070277-A1 METAL COMPLEX, AND COMPOSITION AND LIGHT EMITTING DEVICE CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US disclosed
US-20220403234-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-12-22 US disclosed
CN-113383438-B Organic electroluminescent element 索路思高新材料有限公司 2022-11-01 CN disclosed
CN-113512038-B Benzo [4,5] imidazo [1,2-a ] pyridine derivative and preparation method and application thereof 华南师范大学 2022-08-05 CN disclosed
CN-113054122-B Preparation method of inorganic nano material, inorganic nano material and light-emitting diode TCL科技集团股份有限公司 2022-06-07 CN disclosed
US-11339134-B2 Composition and light emitting element device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2022-05-24 US disclosed
EP-0983054-A1 HAIR GROWTH COMPOSITIONS AND USES GPI NIL Holdings, Inc. (US) 2000-03-08 EP disclosed
WO-2000009107-A2 SULFONAMIDES OF N-CONTAINING HETEROCYCLIC THIOESTERS FOR VISION AND MEMORY DISORDERS GPI NIL HOLDINGS, INC. (US) 2000-02-24 WO disclosed
WO-2000009108-A2 COMPOSITIONS AND USES FOR VISION AND MEMORY DISORDERS GPI NIL HOLDINGS, INC. (US) 2000-02-24 WO disclosed
US-6004993-A TREATMENT OF ALOPECIA IN ANIMALS GPI NIL HOLDINGS, INC. (US) 1999-12-21 US disclosed
WO-1999062489-A1 N-LINKED SULFONAMIDE OF HETEROCYCLIC THIOESTER HAIR GROWTH COMPOUNDS AND USES GPI NIL HOLDINGS, INC. (US) 1999-12-09 WO disclosed
EP-0957913-A1 N-LINKED SULFONAMIDES OF HETEROCYCLIC THIOESTERS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-24 EP disclosed
WO-1998055090-A1 HAIR GROWTH COMPOSITIONS AND USES GUILFORD PHARMACEUTICALS INC. (US) 1998-12-10 WO disclosed
WO-1998029116-A1 N-LINKED SULFONAMIDES OF HETEROCYCLIC THIOESTERS GUILFORD PHARMACEUTICALS INC. (US) 1998-07-09 WO disclosed
US-4158099-A FROM SCHIFF BASES AND BIPHENYL COMPOUND CIBA-GEIGY AG (CH) 1979-06-12 US disclosed
US-3991049-A Aromatic compounds containing ethylene double bonds, processes for their manufacture and use CIBA-GEIGY AG (CH) 1976-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220403234-A1 METAL COMPLEX AND LIGHT EMITTING DEVICE CONTAINING THE SAME RB1, CRY1, RBX1 ACHE 3729/4885LMNA 1960/4885TSHR 1907/4885
US-20230070277-A1 METAL COMPLEX, AND COMPOSITION AND LIGHT EMITTING DEVICE CONTAINING THE SAME SOD1, GPX1, AP1M1 ACHE 1009/4885LMNA 4008/4885TSHR 4331/4885
US-20230371370-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE AND COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE OXER1, OR10J3, OCIAD1 ACHE 469/4885LMNA 4856/4885TSHR 3775/4885
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR ACHE 4478/4885LMNA 2750/4885TSHR 1615/4885
US-11800794-B2 Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device OXER1, OCIAD1, OCIAD2 ACHE 530/4885LMNA 4800/4885TSHR 3948/4885
US-11339134-B2 Composition and light emitting element device using the same CRY1, GNA11, AP2A1 ACHE 3284/4885LMNA 1647/4885TSHR 1835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.